Xiaojian Gu

743 total citations
18 papers, 310 citations indexed

About

Xiaojian Gu is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Urology. According to data from OpenAlex, Xiaojian Gu has authored 18 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Urology. Recurrent topics in Xiaojian Gu's work include Kidney Stones and Urolithiasis Treatments (7 papers), Pediatric Urology and Nephrology Studies (5 papers) and Urinary Bladder and Prostate Research (5 papers). Xiaojian Gu is often cited by papers focused on Kidney Stones and Urolithiasis Treatments (7 papers), Pediatric Urology and Nephrology Studies (5 papers) and Urinary Bladder and Prostate Research (5 papers). Xiaojian Gu collaborates with scholars based in China and Italy. Xiaojian Gu's co-authors include Lin Li, Meilin Wang, Yuan Lin, Fei Zhou, Guangfa Zhu, Binghuai Lu, Bin Cao, Rao Sun, Guohui Fan and Jianfeng Shao and has published in prestigious journals such as PLoS ONE, Brain Research and The Journal of Urology.

In The Last Decade

Xiaojian Gu

17 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiaojian Gu China	11	134	84	75	67	46	18	310
Ashish Sharma India	9	78 0.6×	46 0.5×	35 0.5×	30 0.4×	17 0.4×	62	255
Fp Selvaggi Italy	11	128 1.0×	19 0.2×	25 0.3×	45 0.7×	23 0.5×	33	365
Beáta Hargitai Hungary	11	73 0.5×	191 2.3×	54 0.7×	42 0.6×	20 0.4×	25	444
Chun-Nung Huang Taiwan	9	138 1.0×	74 0.9×	69 0.9×	32 0.5×	28 0.6×	17	315
Pietro D’Alessandro Italy	17	55 0.4×	181 2.2×	50 0.7×	43 0.6×	28 0.6×	30	681
Osama Alomar Saudi Arabia	11	41 0.3×	33 0.4×	52 0.7×	49 0.7×	48 1.0×	66	404
Steve K. Williams United States	14	376 2.8×	80 1.0×	128 1.7×	15 0.2×	17 0.4×	24	558
Guomei Cheng China	12	26 0.2×	75 0.9×	93 1.2×	60 0.9×	60 1.3×	18	340
Meredith P. Schuh United States	8	54 0.4×	53 0.6×	132 1.8×	17 0.3×	12 0.3×	17	299
M. C. Bishop United Kingdom	11	70 0.5×	19 0.2×	114 1.5×	41 0.6×	23 0.5×	20	346

Countries citing papers authored by Xiaojian Gu

Since Specialization

Citations

This map shows the geographic impact of Xiaojian Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Gu more than expected).

Fields of papers citing papers by Xiaojian Gu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Gu. The network helps show where Xiaojian Gu may publish in the future.

Co-authorship network of co-authors of Xiaojian Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Gu. A scholar is included among the top collaborators of Xiaojian Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Gu. Xiaojian Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Gu, Xiaojian, et al.. (2021). Fluoxetine, a selective serotonin reuptake inhibitor used clinically, improves bladder function in a mouse model of moderate spinal cord injury. Neural Regeneration Research. 16(10). 2093–2093. 11 indexed citations

Ma, Long, et al.. (2021). The role of lumbosacral innervating noradrenergic neurons in micturition control. Brain Research. 1777. 147754–147754. 1 indexed citations

Gu, Xiaojian, Guohui Fan, Rao Sun, et al.. (2019). Evaluation of a molecular point-of-care testing for viral and atypical pathogens on intravenous antibiotic duration in hospitalized adults with lower respiratory tract infection: a randomized clinical trial. Clinical Microbiology and Infection. 25(11). 1415–1421. 59 indexed citations

Zhang, Yifan, Changbao Xu, Youzhi Wang, et al.. (2019). When is the best time to perform external physical vibration lithecbole (EPVL) after retrograde intrarenal surgery (RIRS): a multi-center study based on randomized controlled trials. Urolithiasis. 48(6). 533–539. 10 indexed citations

Gu, Xiaojian, Guohui Fan, Fei Zhou, et al.. (2019). The Clinical Value of a New Molecular Point-of-Care Testing in Hospitalized Lower Respiratory Tract Infection Patients: A Randomized Controlled Study. A4209–A4209.

Gu, Xiaojian, et al.. (2018). Current opinions on nephrolithiasis associated with primary hyperparathyroidism. Urolithiasis. 46(5). 453–457. 14 indexed citations

Zhang, Xin, et al.. (2017). Clinical and genetic characterization of Chinese pediatric cystine stone patients. Journal of Pediatric Urology. 13(6). 629.e1–629.e5. 11 indexed citations

Wu, Wenqi, Yang Zhou, Changbao Xu, et al.. (2017). External Physical Vibration Lithecbole Promotes the Clearance of Upper Urinary Stones after Retrograde Intrarenal Surgery: A Prospective, Multicenter, Randomized Controlled Trial. The Journal of Urology. 197(5). 1289–1295. 19 indexed citations

Wu, Wenqi, Yang Zhou, Changbao Xu, et al.. (2017). How to accelerate the upper urinary stone discharge after extracorporeal shockwave lithotripsy (ESWL) for < 15 mm upper urinary stones: a prospective multi-center randomized controlled trial about external physical vibration lithecbole (EPVL). World Journal of Urology. 36(2). 293–298. 12 indexed citations

10.

Gu, Xiaojian, Zhengyu Zhang, Zhongqing Wei, et al.. (2015). [Efficacy and safety of Saw Palmetto Extract Capsules in the treatment of benign prostatic hyperplasia].. PubMed. 21(12). 1098–101. 3 indexed citations

11.

Chen, Xuehua, et al.. (2014). High-dose Supplementation With Vitamin C–induced Pediatric Urolithiasis: The First Case Report in a Child and Literature Review. Urology. 84(4). 922–924. 9 indexed citations

12.

Gu, Xiaojian, et al.. (2013). The true stone composition and abnormality of urinary metabolic lithogenic factors of rats fed diets containing melamine. Urolithiasis. 42(3). 227–232. 1 indexed citations

13.

Lin, Yuan, Haiyan Chu, Meilin Wang, et al.. (2013). Genetic Variation in DROSHA 3’UTR Regulated by hsa-miR-27b Is Associated with Bladder Cancer Risk. PLoS ONE. 8(11). e81524–e81524. 44 indexed citations

14.

Gu, Xiaojian, et al.. (2013). Possible Function of Urinary pH and Citrate on the Ceftriaxone-induced Nephrolithiasis. Urology. 83(1). 63–67. 8 indexed citations

15.

Gu, Xiaojian, et al.. (2013). Treatment of large impacted proximal ureteral stones: randomized comparison of minimally invasive percutaneous antegrade ureterolithotripsy versus retrograde ureterolithotripsy. World Journal of Urology. 31(6). 1605–1610. 49 indexed citations

16.

Lin, Yuan, Xiaojian Gu, Jianfeng Shao, et al.. (2010). Cyclin D1 G870A Polymorphism Is Associated with Risk and Clinicopathologic Characteristics of Bladder Cancer. DNA and Cell Biology. 29(10). 611–617. 31 indexed citations

17.

Lin, Yuan, et al.. (2009). Unfavorable Prognostic Value of Human PEDF Decreased in High-Grade Prostatic Intraepithelial Neoplasia: A Differential Proteomics Approach. Cancer Investigation. 27(7). 794–801. 25 indexed citations

18.

Gu, Xiaojian, Li Zhang, Zijie Lu, et al.. (2008). [TUBVP and HOLEP: desirable surgical options for large benign prostatic hyperplasia ( >80 ml)].. PubMed. 14(10). 907–10. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact